Abbott Laboratories
ABT
$133.70
Share price
-0.55%
Change (1 day)
30.92%
Change (1 year)
Categories
Abbott Laboratories (ABT), (founding name: Abbott Alkaloid Company) is a global pharmaceutical company with around 73,000 employees in 150 countries. Abbott was founded in 1888 by Wallace C. Abbott (1857-1921) and is headquartered in Abbott Park, a northern suburb of Chicago, Illinois.
Abbott Laboratories (ABT) - Cash on Hand
Cash on Hand as of March 2025 : $6.84 Billion USD
According to Abbott Laboratories's latest financial reports the company has $6.84 Billion USD in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Abbott Laboratories - Cash on Hand chart (from 1996 to 2025)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2024-12-31 | $7.96 B | 9.45% |
| 2023-12-31 | $7.27 B | -28.43% |
| 2022-12-31 | $10.17 B | -0.77% |
| 2021-12-31 | $10.24 B | 43.38% |
| 2020-12-31 | $7.14 B | 72.66% |
| 2019-12-31 | $4.14 B | 1.32% |
| 2018-12-31 | $4.08 B | -57.48% |
| 2017-12-31 | $9.61 B | -48.81% |
| 2016-12-31 | $18.77 B | 206.53% |
| 2015-12-31 | $6.12 B | 37.33% |
| 2014-12-31 | $4.46 B | -44.92% |
| 2013-12-31 | $8.09 B | -46.63% |
| 2012-12-31 | $15.17 B | 87.39% |
| 2011-12-31 | $8.09 B | 48.54% |
| 2010-12-31 | $5.45 B | -45.11% |
| 2009-12-31 | $9.93 B | 95.53% |
| 2008-12-31 | $5.07 B | 80.08% |
| 2007-12-31 | $2.82 B | 105.38% |
| 2006-12-31 | $1.37 B | -53.54% |
| 2005-12-31 | $2.95 B | 43.57% |
| 2004-12-31 | $2.05 B | 60.05% |
| 2003-12-31 | $1.28 B | 33.15% |
| 2002-12-31 | $0.96 B | 35.4% |
| 2001-12-31 | $0.71 B | -38.31% |
| 2000-12-31 | $1.15 B | 59.92% |
| 1999-12-31 | $0.72 B | 75.98% |
| 1998-12-31 | $0.41 B | 78.7% |
| 1997-12-31 | $0.23 B | 108.71% |
| 1996-12-31 | $0.11 B |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $38.78 B | 466.64% | 🇺🇸 USA |
 Pfizer PFE | $17.31 B | 153.01% | 🇺🇸 USA |
 Thermo Fisher Scientific TMO | $5.94 B | -13.11% | 🇺🇸 USA |
 Hologic HOLX | $1.62 B | -76.32% | 🇺🇸 USA |
 Medtronic MDT | $8.96 B | 30.99% | 🇮🇪 Ireland |
 Bristol-Myers Squibb BMY | $11.78 B | 72.15% | 🇺🇸 USA |
 Boston Scientific BSX | $0.72 B | -89.41% | 🇺🇸 USA |
 AstraZeneca AZN | $5.39 B | -21.17% | 🇬🇧 UK |
 Novartis NVS | $7.19 B | 5.14% | 🇨🇭 Switzerland |
 GlaxoSmithKline GSK | $5.79 B | -15.33% | 🇬🇧 UK |